Clinical Trial Update: An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005) [Phase 2]

View source ↗

Summary

Results from an active-controlled Phase 2 study of MK-8189 in adults with schizophrenia (acute episode) have been posted. The trial status was completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• MK-8189

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Schizophrenia, Acute Episode | Phase 2 | Status: COMPLETED | Results posted: 2018-12-26